Global Metabolomics Biomarker Market Research Report 2023

Report ID: 1991673 | Published Date: Jan 2025 | No. of Page: 89 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Metabolomics Biomarker Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Protein Marker
        1.2.3 Nucleic Acid Marker
    1.3 Market by Application
        1.3.1 Global Metabolomics Biomarker Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Toxicological studies
        1.3.3 Drug testing
        1.3.4 Cancer
        1.3.5 Cardiovascular disorders
        1.3.6 Neurological disorders
        1.3.7 Inborn errors of metabolism
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Metabolomics Biomarker Market Perspective (2017-2028)
    2.2 Metabolomics Biomarker Growth Trends by Region
        2.2.1 Metabolomics Biomarker Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Metabolomics Biomarker Historic Market Size by Region (2017-2022)
        2.2.3 Metabolomics Biomarker Forecasted Market Size by Region (2023-2028)
    2.3 Metabolomics Biomarker Market Dynamics
        2.3.1 Metabolomics Biomarker Industry Trends
        2.3.2 Metabolomics Biomarker Market Drivers
        2.3.3 Metabolomics Biomarker Market Challenges
        2.3.4 Metabolomics Biomarker Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Metabolomics Biomarker Players by Revenue
        3.1.1 Global Top Metabolomics Biomarker Players by Revenue (2017-2022)
        3.1.2 Global Metabolomics Biomarker Revenue Market Share by Players (2017-2022)
    3.2 Global Metabolomics Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Metabolomics Biomarker Revenue
    3.4 Global Metabolomics Biomarker Market Concentration Ratio
        3.4.1 Global Metabolomics Biomarker Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Metabolomics Biomarker Revenue in 2021
    3.5 Metabolomics Biomarker Key Players Head office and Area Served
    3.6 Key Players Metabolomics Biomarker Product Solution and Service
    3.7 Date of Enter into Metabolomics Biomarker Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Metabolomics Biomarker Breakdown Data by Type
    4.1 Global Metabolomics Biomarker Historic Market Size by Type (2017-2022)
    4.2 Global Metabolomics Biomarker Forecasted Market Size by Type (2023-2028)
5 Metabolomics Biomarker Breakdown Data by Application
    5.1 Global Metabolomics Biomarker Historic Market Size by Application (2017-2022)
    5.2 Global Metabolomics Biomarker Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Metabolomics Biomarker Market Size (2017-2028)
    6.2 North America Metabolomics Biomarker Market Size by Country (2017-2022)
    6.3 North America Metabolomics Biomarker Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Metabolomics Biomarker Market Size (2017-2028)
    7.2 Europe Metabolomics Biomarker Market Size by Country (2017-2022)
    7.3 Europe Metabolomics Biomarker Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Metabolomics Biomarker Market Size (2017-2028)
    8.2 Asia-Pacific Metabolomics Biomarker Market Size by Country (2017-2022)
    8.3 Asia-Pacific Metabolomics Biomarker Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Metabolomics Biomarker Market Size (2017-2028)
    9.2 Latin America Metabolomics Biomarker Market Size by Country (2017-2022)
    9.3 Latin America Metabolomics Biomarker Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Metabolomics Biomarker Market Size (2017-2028)
    10.2 Middle East & Africa Metabolomics Biomarker Market Size by Country (2017-2022)
    10.3 Middle East & Africa Metabolomics Biomarker Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Biocrates Life Sciences
        11.1.1 Biocrates Life Sciences Company Detail
        11.1.2 Biocrates Life Sciences Business Overview
        11.1.3 Biocrates Life Sciences Metabolomics Biomarker Introduction
        11.1.4 Biocrates Life Sciences Revenue in Metabolomics Biomarker Business (2017-2022)
        11.1.5 Biocrates Life Sciences Recent Development
    11.2 Biomark Diagnostics
        11.2.1 Biomark Diagnostics Company Detail
        11.2.2 Biomark Diagnostics Business Overview
        11.2.3 Biomark Diagnostics Metabolomics Biomarker Introduction
        11.2.4 Biomark Diagnostics Revenue in Metabolomics Biomarker Business (2017-2022)
        11.2.5 Biomark Diagnostics Recent Development
    11.3 Chenomx
        11.3.1 Chenomx Company Detail
        11.3.2 Chenomx Business Overview
        11.3.3 Chenomx Metabolomics Biomarker Introduction
        11.3.4 Chenomx Revenue in Metabolomics Biomarker Business (2017-2022)
        11.3.5 Chenomx Recent Development
    11.4 Creative Proteomics
        11.4.1 Creative Proteomics Company Detail
        11.4.2 Creative Proteomics Business Overview
        11.4.3 Creative Proteomics Metabolomics Biomarker Introduction
        11.4.4 Creative Proteomics Revenue in Metabolomics Biomarker Business (2017-2022)
        11.4.5 Creative Proteomics Recent Development
    11.5 Evotec
        11.5.1 Evotec Company Detail
        11.5.2 Evotec Business Overview
        11.5.3 Evotec Metabolomics Biomarker Introduction
        11.5.4 Evotec Revenue in Metabolomics Biomarker Business (2017-2022)
        11.5.5 Evotec Recent Development
    11.6 Human Metabolome Technologies
        11.6.1 Human Metabolome Technologies Company Detail
        11.6.2 Human Metabolome Technologies Business Overview
        11.6.3 Human Metabolome Technologies Metabolomics Biomarker Introduction
        11.6.4 Human Metabolome Technologies Revenue in Metabolomics Biomarker Business (2017-2022)
        11.6.5 Human Metabolome Technologies Recent Development
    11.7 Merck
        11.7.1 Merck Company Detail
        11.7.2 Merck Business Overview
        11.7.3 Merck Metabolomics Biomarker Introduction
        11.7.4 Merck Revenue in Metabolomics Biomarker Business (2017-2022)
        11.7.5 Merck Recent Development
    11.8 Metabolomic Diagnostics
        11.8.1 Metabolomic Diagnostics Company Detail
        11.8.2 Metabolomic Diagnostics Business Overview
        11.8.3 Metabolomic Diagnostics Metabolomics Biomarker Introduction
        11.8.4 Metabolomic Diagnostics Revenue in Metabolomics Biomarker Business (2017-2022)
        11.8.5 Metabolomic Diagnostics Recent Development
    11.9 Metabolon
        11.9.1 Metabolon Company Detail
        11.9.2 Metabolon Business Overview
        11.9.3 Metabolon Metabolomics Biomarker Introduction
        11.9.4 Metabolon Revenue in Metabolomics Biomarker Business (2017-2022)
        11.9.5 Metabolon Recent Development
    11.10 Ovid Therapeutics
        11.10.1 Ovid Therapeutics Company Detail
        11.10.2 Ovid Therapeutics Business Overview
        11.10.3 Ovid Therapeutics Metabolomics Biomarker Introduction
        11.10.4 Ovid Therapeutics Revenue in Metabolomics Biomarker Business (2017-2022)
        11.10.5 Ovid Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Metabolomics Biomarker Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Protein Marker
    Table 3. Key Players of Nucleic Acid Marker
    Table 4. Global Metabolomics Biomarker Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Metabolomics Biomarker Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Metabolomics Biomarker Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Metabolomics Biomarker Market Share by Region (2017-2022)
    Table 8. Global Metabolomics Biomarker Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Metabolomics Biomarker Market Share by Region (2023-2028)
    Table 10. Metabolomics Biomarker Market Trends
    Table 11. Metabolomics Biomarker Market Drivers
    Table 12. Metabolomics Biomarker Market Challenges
    Table 13. Metabolomics Biomarker Market Restraints
    Table 14. Global Metabolomics Biomarker Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Metabolomics Biomarker Market Share by Players (2017-2022)
    Table 16. Global Top Metabolomics Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabolomics Biomarker as of 2021)
    Table 17. Ranking of Global Top Metabolomics Biomarker Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Metabolomics Biomarker Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Metabolomics Biomarker Product Solution and Service
    Table 21. Date of Enter into Metabolomics Biomarker Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Metabolomics Biomarker Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Metabolomics Biomarker Revenue Market Share by Type (2017-2022)
    Table 25. Global Metabolomics Biomarker Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Metabolomics Biomarker Revenue Market Share by Type (2023-2028)
    Table 27. Global Metabolomics Biomarker Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Metabolomics Biomarker Revenue Market Share by Application (2017-2022)
    Table 29. Global Metabolomics Biomarker Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Metabolomics Biomarker Revenue Market Share by Application (2023-2028)
    Table 31. North America Metabolomics Biomarker Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Metabolomics Biomarker Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Metabolomics Biomarker Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Metabolomics Biomarker Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Metabolomics Biomarker Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Metabolomics Biomarker Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Metabolomics Biomarker Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Metabolomics Biomarker Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Metabolomics Biomarker Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Metabolomics Biomarker Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Biocrates Life Sciences Company Detail
    Table 42. Biocrates Life Sciences Business Overview
    Table 43. Biocrates Life Sciences Metabolomics Biomarker Product
    Table 44. Biocrates Life Sciences Revenue in Metabolomics Biomarker Business (2017-2022) & (US$ Million)
    Table 45. Biocrates Life Sciences Recent Development
    Table 46. Biomark Diagnostics Company Detail
    Table 47. Biomark Diagnostics Business Overview
    Table 48. Biomark Diagnostics Metabolomics Biomarker Product
    Table 49. Biomark Diagnostics Revenue in Metabolomics Biomarker Business (2017-2022) & (US$ Million)
    Table 50. Biomark Diagnostics Recent Development
    Table 51. Chenomx Company Detail
    Table 52. Chenomx Business Overview
    Table 53. Chenomx Metabolomics Biomarker Product
    Table 54. Chenomx Revenue in Metabolomics Biomarker Business (2017-2022) & (US$ Million)
    Table 55. Chenomx Recent Development
    Table 56. Creative Proteomics Company Detail
    Table 57. Creative Proteomics Business Overview
    Table 58. Creative Proteomics Metabolomics Biomarker Product
    Table 59. Creative Proteomics Revenue in Metabolomics Biomarker Business (2017-2022) & (US$ Million)
    Table 60. Creative Proteomics Recent Development
    Table 61. Evotec Company Detail
    Table 62. Evotec Business Overview
    Table 63. Evotec Metabolomics Biomarker Product
    Table 64. Evotec Revenue in Metabolomics Biomarker Business (2017-2022) & (US$ Million)
    Table 65. Evotec Recent Development
    Table 66. Human Metabolome Technologies Company Detail
    Table 67. Human Metabolome Technologies Business Overview
    Table 68. Human Metabolome Technologies Metabolomics Biomarker Product
    Table 69. Human Metabolome Technologies Revenue in Metabolomics Biomarker Business (2017-2022) & (US$ Million)
    Table 70. Human Metabolome Technologies Recent Development
    Table 71. Merck Company Detail
    Table 72. Merck Business Overview
    Table 73. Merck Metabolomics Biomarker Product
    Table 74. Merck Revenue in Metabolomics Biomarker Business (2017-2022) & (US$ Million)
    Table 75. Merck Recent Development
    Table 76. Metabolomic Diagnostics Company Detail
    Table 77. Metabolomic Diagnostics Business Overview
    Table 78. Metabolomic Diagnostics Metabolomics Biomarker Product
    Table 79. Metabolomic Diagnostics Revenue in Metabolomics Biomarker Business (2017-2022) & (US$ Million)
    Table 80. Metabolomic Diagnostics Recent Development
    Table 81. Metabolon Company Detail
    Table 82. Metabolon Business Overview
    Table 83. Metabolon Metabolomics Biomarker Product
    Table 84. Metabolon Revenue in Metabolomics Biomarker Business (2017-2022) & (US$ Million)
    Table 85. Metabolon Recent Development
    Table 86. Ovid Therapeutics Company Detail
    Table 87. Ovid Therapeutics Business Overview
    Table 88. Ovid Therapeutics Metabolomics Biomarker Product
    Table 89. Ovid Therapeutics Revenue in Metabolomics Biomarker Business (2017-2022) & (US$ Million)
    Table 90. Ovid Therapeutics Recent Development
    Table 91. Research Programs/Design for This Report
    Table 92. Key Data Information from Secondary Sources
    Table 93. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Metabolomics Biomarker Market Share by Type: 2021 VS 2028
    Figure 2. Protein Marker Features
    Figure 3. Nucleic Acid Marker Features
    Figure 4. Global Metabolomics Biomarker Market Share by Application in 2021 & 2028
    Figure 5. Toxicological studies Case Studies
    Figure 6. Drug testing Case Studies
    Figure 7. Cancer Case Studies
    Figure 8. Cardiovascular disorders Case Studies
    Figure 9. Neurological disorders Case Studies
    Figure 10. Inborn errors of metabolism Case Studies
    Figure 11. Metabolomics Biomarker Report Years Considered
    Figure 12. Global Metabolomics Biomarker Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Metabolomics Biomarker Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Metabolomics Biomarker Market Share by Region: 2021 VS 2028
    Figure 15. Global Metabolomics Biomarker Market Share by Players in 2021
    Figure 16. Global Top Metabolomics Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabolomics Biomarker as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Metabolomics Biomarker Revenue in 2021
    Figure 18. North America Metabolomics Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. North America Metabolomics Biomarker Market Share by Country (2017-2028)
    Figure 20. United States Metabolomics Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Metabolomics Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Metabolomics Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Metabolomics Biomarker Market Share by Country (2017-2028)
    Figure 24. Germany Metabolomics Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France Metabolomics Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. Metabolomics Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy Metabolomics Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia Metabolomics Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries Metabolomics Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Metabolomics Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Metabolomics Biomarker Market Share by Region (2017-2028)
    Figure 32. China Metabolomics Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Japan Metabolomics Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. South Korea Metabolomics Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Southeast Asia Metabolomics Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. India Metabolomics Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Australia Metabolomics Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Metabolomics Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Metabolomics Biomarker Market Share by Country (2017-2028)
    Figure 40. Mexico Metabolomics Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Brazil Metabolomics Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Metabolomics Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Metabolomics Biomarker Market Share by Country (2017-2028)
    Figure 44. Turkey Metabolomics Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Saudi Arabia Metabolomics Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Biocrates Life Sciences Revenue Growth Rate in Metabolomics Biomarker Business (2017-2022)
    Figure 47. Biomark Diagnostics Revenue Growth Rate in Metabolomics Biomarker Business (2017-2022)
    Figure 48. Chenomx Revenue Growth Rate in Metabolomics Biomarker Business (2017-2022)
    Figure 49. Creative Proteomics Revenue Growth Rate in Metabolomics Biomarker Business (2017-2022)
    Figure 50. Evotec Revenue Growth Rate in Metabolomics Biomarker Business (2017-2022)
    Figure 51. Human Metabolome Technologies Revenue Growth Rate in Metabolomics Biomarker Business (2017-2022)
    Figure 52. Merck Revenue Growth Rate in Metabolomics Biomarker Business (2017-2022)
    Figure 53. Metabolomic Diagnostics Revenue Growth Rate in Metabolomics Biomarker Business (2017-2022)
    Figure 54. Metabolon Revenue Growth Rate in Metabolomics Biomarker Business (2017-2022)
    Figure 55. Ovid Therapeutics Revenue Growth Rate in Metabolomics Biomarker Business (2017-2022)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Biocrates Life Sciences
Biomark Diagnostics
Chenomx
Creative Proteomics
Evotec
Human Metabolome Technologies
Merck
Metabolomic Diagnostics
Metabolon
Ovid Therapeutics
Frequently Asked Questions
Metabolomics Biomarker report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Metabolomics Biomarker report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Metabolomics Biomarker report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Natural Refrigerant

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More